---
title: "000919.SZ (000919.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/000919.SZ/news.md"
symbol: "000919.SZ"
name: "000919.SZ"
parent: "https://longbridge.com/en/quote/000919.SZ.md"
datetime: "2026-05-20T10:20:22.866Z"
locales:
  - [en](https://longbridge.com/en/quote/000919.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/000919.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/000919.SZ/news.md)
---

# 000919.SZ (000919.SZ) — Related News

### [Looking for a "lifeline," why is the 50-year-old pharmaceutical company Changzhou Siyao in a hurry to "sell itself"?](https://longbridge.com/en/news/283934718.md)
*2026-04-24T04:35:02.000Z*
> JINLING PHARM. plans to acquire 100% equity of Changzhou Sihua in cash. Changzhou Sihua is an established pharmaceutical

### [](https://longbridge.com/en/news/283423182.md)
*2026-04-21T01:40:16.000Z*
> The A-share pharmaceutical sector was active at the beginning of the trading session, with YIBAI PHARMACEUTICAL hitting 

### [JINLING PHARM.'s drug listing application was not approved, with a non-recurring profit drop of 28.45%, while the chairman's salary increased by 27%](https://longbridge.com/en/news/283075935.md)
*2026-04-17T01:40:42.000Z*
> JINLING PHARM. recently faced a setback as its subsidiary, JINLING Pharmaceutical Factory, had its drug listing applicat

### [JINLING PHARM. branch received a notice of disapproval for the drug market application](https://longbridge.com/en/news/282803166.md)
*2026-04-15T07:50:03.000Z*
> JINLING PHARM. announced that its subsidiary Nanjing JINLING Pharmaceutical Factory recently received a "Notice of Disap

### [A-share closing review: Shanghai Composite Index slightly rose by 0.01%, ChiNext Index fell over 1%, ending a 5-day winning streak; pharmaceutical stocks surged against the trend, while computing power leasing and commercial aerospace concept stocks were active](https://longbridge.com/en/news/282799422.md)
*2026-04-15T07:17:28.000Z*
> On April 15th, the A-share market showed a mixed performance, with the Shanghai Composite Index slightly rising by 0.01%

### [April 15 Midday Market Review: GEM Index Opens High and Falls, Closing Down 0.23%; Innovative Drug Concepts Rally Collectively](https://longbridge.com/en/news/282777450.md)
*2026-04-15T03:30:59.000Z*
> As of the midday close on April 15, the Shanghai Composite Index rose 0.37%, the Shenzhen Component Index fell 0.25%, an

### [](https://longbridge.com/en/news/282773359.md)
*2026-04-15T02:40:37.000Z*
> A-shares of innovative drugs strengthened, Huaren Health approached a 20% limit-up, Realcan, HISUN, JINLING PHARM., and 

### [JINLING PHARM. intends to acquire equity in Changzhou Siyao Company](https://longbridge.com/en/news/282534982.md)
*2026-04-13T11:27:04.000Z*
> JINLING PHARM. announced that the company intends to participate in the selection of strategic investors for Changzhou S